Zivo Bioscience, Inc. (ZIVOW) SEC Filings — 2024
19 SEC filings for Zivo Bioscience, Inc. (ZIVOW) in 2024.
Filings
- Zivo Bioscience Secures New Loan Agreement — 8-K · Nov 15, 2024
- Zivo Bioscience Reports Q3 Loss, Completes Private Placements — 10-Q · Nov 14, 2024
- Zivo Bioscience Files 8-K on Equity Sale — 8-K · Oct 18, 2024
- HEP Investments LLC Amends Zivo Bioscience 13D Filing — SC 13D/A · Oct 1, 2024
- Zivo Bioscience Q2 2024: No Revenue, Net Loss — 10-Q · Aug 14, 2024
- Zivo Bioscience Announces Board Changes and New CFO — 8-K · Jul 17, 2024
- Zivo Bioscience Reports on Shareholder Vote Matters — 8-K · Jun 13, 2024
- Marchiando Files 13D for Zivo Bioscience — SC 13D · Jun 12, 2024
- Zivo Bioscience Corrects Director Fee Stock Award Date — 8-K/A · Jun 7, 2024
- Zivo Bioscience Files 8-K: Agreements, Personnel Changes — 8-K · Jun 6, 2024
- Zivo Bioscience Files 10-Q for Q1 2024 — 10-Q · May 13, 2024
- Zivo Bioscience, Inc. Announces 2024 Annual Meeting of Shareholders — DEF 14A · Apr 26, 2024
- Strome Group Adjusts Zivo Bioscience Stake — SC 13D/A · Apr 9, 2024
- Zivo Bioscience, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 15, 2024
- Zivo Bioscience Receives Delisting Notice — 8-K · Feb 15, 2024
- Maggiore Amends Zivo Bioscience Stake, Signals Ownership Shift — SC 13D · Jan 22, 2024
- ZIVO Reports Unregistered Equity Sales on Dec 5, 2023 — 8-K · Jan 17, 2024
- ZIVO Reports Unregistered Equity Sales on Dec 5, 2023 — 8-K · Jan 5, 2024
- ZIVO Reports Unregistered Equity Sales on Dec 5, 2203 — 8-K · Jan 3, 2024